ID   AP2A2_RAT               Reviewed;         938 AA.
AC   P18484;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 186.
DE   RecName: Full=AP-2 complex subunit alpha-2 {ECO:0000305};
DE   AltName: Full=100 kDa coated vesicle protein C;
DE   AltName: Full=Adaptor protein complex AP-2 subunit alpha-2;
DE   AltName: Full=Adaptor-related protein complex 2 subunit alpha-2;
DE   AltName: Full=Alpha-adaptin C;
DE   AltName: Full=Alpha2-adaptin;
DE   AltName: Full=Clathrin assembly protein complex 2 alpha-C large chain;
DE   AltName: Full=Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit;
GN   Name=Ap2a2 {ECO:0000312|RGD:71015}; Synonyms=Adtab;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2402467; DOI=10.1093/nar/18.17.5306;
RA   Tucker K.L., Nathanson K., Kirchhausen T.;
RT   "Sequence of the rat alpha c large chain of the clathrin associated protein
RT   complex AP-2.";
RL   Nucleic Acids Res. 18:5306-5306(1990).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-18.
RC   TISSUE=Brain;
RX   PubMed=2495531; DOI=10.1073/pnas.86.8.2612;
RA   Kirchhausen T., Nathanson K.L., Matsui W., Vaisberg A., Chow E.P.,
RA   Burne C., Keen J.H., Davis A.E.;
RT   "Structural and functional division into two domains of the large (100- to
RT   115-kDa) chains of the clathrin-associated protein complex AP-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:2612-2616(1989).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-18.
RX   PubMed=1325787; DOI=10.1016/s0006-291x(05)81473-1;
RA   Voglmaier S.M., Keen J.H., Murphy J.E., Ferris C.D., Prestwich G.D.,
RA   Snyder S.H., Theibert A.B.;
RT   "Inositol hexakisphosphate receptor identified as the clathrin assembly
RT   protein AP-2.";
RL   Biochem. Biophys. Res. Commun. 187:158-163(1992).
RN   [4]
RP   FUNCTION OF THE AP-2 COMPLEX IN CLATHRIN-MEDIATED ENDOCYTOSIS.
RX   PubMed=14745134; DOI=10.1247/csf.28.419;
RA   Nakatsu F., Ohno H.;
RT   "Adaptor protein complexes as the key regulators of protein sorting in the
RT   post-Golgi network.";
RL   Cell Struct. Funct. 28:419-429(2003).
RN   [5]
RP   FUNCTION OF THE AP-2 COMPLEX IN CLATHRIN-MEDIATED ENDOCYTOSIS.
RX   PubMed=15473838; DOI=10.1146/annurev.cellbio.20.010403.104543;
RA   Owen D.J., Collins B.M., Evans P.R.;
RT   "Adaptors for clathrin coats: structure and function.";
RL   Annu. Rev. Cell Dev. Biol. 20:153-191(2004).
RN   [6]
RP   INTERACTION WITH ABCB11.
RX   PubMed=22262466; DOI=10.1002/hep.25591;
RA   Hayashi H., Inamura K., Aida K., Naoi S., Horikawa R., Nagasaka H.,
RA   Takatani T., Fukushima T., Hattori A., Yabuki T., Horii I., Sugiyama Y.;
RT   "AP2 adaptor complex mediates bile salt export pump internalization and
RT   modulates its hepatocanalicular expression and transport function.";
RL   Hepatology 55:1889-1900(2012).
RN   [7] {ECO:0007744|PDB:2VGL}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 1-620 IN COMPLEX WITH AP2B1;
RP   AP2M1; AP2S1 AND INOSITOL HEXAKISPHOSPHATE.
RX   PubMed=12086608; DOI=10.1016/s0092-8674(02)00735-3;
RA   Collins B.M., McCoy A.J., Kent H.M., Evans P.R., Owen D.J.;
RT   "Molecular architecture and functional model of the endocytic AP2
RT   complex.";
RL   Cell 109:523-535(2002).
RN   [8] {ECO:0007744|PDB:4UQI}
RP   X-RAY CRYSTALLOGRAPHY (2.79 ANGSTROMS) OF 1-620 IN COMPLEX WITH AP2B1;
RP   AP2M1; AP2S1 AND INOSITOL HEXAKISPHOSPHATE.
RX   PubMed=25061211; DOI=10.1126/science.1254836;
RA   Kelly B.T., Graham S.C., Liska N., Dannhauser P.N., Honing S.,
RA   Ungewickell E.J., Owen D.J.;
RT   "Clathrin adaptors. AP2 controls clathrin polymerization with a membrane-
RT   activated switch.";
RL   Science 345:459-463(2014).
CC   -!- FUNCTION: Component of the adaptor protein complex 2 (AP-2). Adaptor
CC       protein complexes function in protein transport via transport vesicles
CC       in different membrane traffic pathways. Adaptor protein complexes are
CC       vesicle coat components and appear to be involved in cargo selection
CC       and vesicle formation. AP-2 is involved in clathrin-dependent
CC       endocytosis in which cargo proteins are incorporated into vesicles
CC       surrounded by clathrin (clathrin-coated vesicles, CCVs) which are
CC       destined for fusion with the early endosome. The clathrin lattice
CC       serves as a mechanical scaffold but is itself unable to bind directly
CC       to membrane components. Clathrin-associated adaptor protein (AP)
CC       complexes which can bind directly to both the clathrin lattice and to
CC       the lipid and protein components of membranes are considered to be the
CC       major clathrin adaptors contributing the CCV formation. AP-2 also
CC       serves as a cargo receptor to selectively sort the membrane proteins
CC       involved in receptor-mediated endocytosis. AP-2 seems to play a role in
CC       the recycling of synaptic vesicle membranes from the presynaptic
CC       surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-
CC       [LI] endocytosis signal motifs within the cytosolic tails of
CC       transmembrane cargo molecules. AP-2 may also play a role in maintaining
CC       normal post-endocytic trafficking through the ARF6-regulated, non-
CC       clathrin pathway. During long-term potentiation in hippocampal neurons,
CC       AP-2 is responsible for the endocytosis of ADAM10 (By similarity). The
CC       AP-2 alpha subunit binds polyphosphoinositide-containing lipids,
CC       positioning AP-2 on the membrane. The AP-2 alpha subunit acts via its
CC       C-terminal appendage domain as a scaffolding platform for endocytic
CC       accessory proteins. The AP-2 alpha and AP-2 sigma subunits are thought
CC       to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif (By
CC       similarity). {ECO:0000250, ECO:0000250|UniProtKB:P17427,
CC       ECO:0000269|PubMed:14745134, ECO:0000269|PubMed:15473838}.
CC   -!- SUBUNIT: Adaptor protein complex 2 (AP-2) is a heterotetramer composed
CC       of two large adaptins (alpha-type subunit AP2A1 or AP2A2 and beta-type
CC       subunit AP2B1), a medium adaptin (mu-type subunit AP2M1) and a small
CC       adaptin (sigma-type subunit AP2S1). Interacts with clathrin (By
CC       similarity). Binds EPN1, EPS15, AMPH, SNAP91 and BIN1 (By similarity).
CC       Interacts with HIP1 (By similarity). Interacts with DGKD (By
CC       similarity). Interacts with DENND1A, DENND1B and DENND1C (By
CC       similarity). Interacts with FCHO1 and DAB2 (By similarity). Interacts
CC       with ATAT1; this interaction is required for efficient alpha-tubulin
CC       acetylation by ATAT1 (By similarity). Interacts with KIAA1107 (By
CC       similarity). Together with AP2B1 and AP2M1, it interacts with ADAM10;
CC       this interaction facilitates ADAM10 endocytosis from the plasma
CC       membrane during long-term potentiation in hippocampal neurons (By
CC       similarity). Interacts with CLN3 (via dileucine motif) (By similarity).
CC       Interacts with ABCB11; this interaction regulates cell membrane
CC       expression of ABCB11 through its internalization in a clathrin-
CC       dependent manner and its subsequent degradation (PubMed:22262466).
CC       Interacts with Cacfd1 (By similarity). Interacts with DNAJC6 (By
CC       similarity). {ECO:0000250|UniProtKB:O94973,
CC       ECO:0000250|UniProtKB:P17427, ECO:0000269|PubMed:22262466}.
CC   -!- INTERACTION:
CC       P18484; P21707: Syt1; NbExp=5; IntAct=EBI-539360, EBI-458098;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P17427};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:P17427}; Cytoplasmic
CC       side {ECO:0000250|UniProtKB:P17427}. Membrane, coated pit
CC       {ECO:0000250|UniProtKB:P17427}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P17427}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P17427}. Note=AP-2 appears to be excluded from
CC       internalizing CCVs and to disengage from sites of endocytosis seconds
CC       before internalization of the nascent CCV.
CC       {ECO:0000250|UniProtKB:P17427}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- SIMILARITY: Belongs to the adaptor complexes large subunit family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X53773; CAA37791.1; -; mRNA.
DR   PIR; S11276; S11276.
DR   PDB; 2VGL; X-ray; 2.59 A; A=1-620.
DR   PDB; 2XA7; X-ray; 3.10 A; A=1-621.
DR   PDB; 4NEE; X-ray; 2.88 A; A/B/G/J=1-395.
DR   PDB; 4UQI; X-ray; 2.79 A; A=1-620.
DR   PDB; 6OWT; EM; 3.80 A; A=1-938.
DR   PDB; 6QH5; X-ray; 2.56 A; A=1-620.
DR   PDB; 6QH6; X-ray; 5.00 A; A=1-620.
DR   PDB; 6QH7; X-ray; 3.40 A; A=1-620.
DR   PDB; 6URI; X-ray; 3.00 A; A=1-620.
DR   PDB; 6YAE; EM; 3.90 A; A=1-620.
DR   PDB; 6YAF; EM; 9.10 A; A=1-622.
DR   PDB; 6YAH; EM; 10.20 A; A=1-622.
DR   PDB; 7OG1; X-ray; 3.25 A; AAA=1-620.
DR   PDB; 7OHO; X-ray; 2.88 A; AAA=1-620.
DR   PDB; 7Z5C; EM; 4.16 A; A=1-620.
DR   PDBsum; 2VGL; -.
DR   PDBsum; 2XA7; -.
DR   PDBsum; 4NEE; -.
DR   PDBsum; 4UQI; -.
DR   PDBsum; 6OWT; -.
DR   PDBsum; 6QH5; -.
DR   PDBsum; 6QH6; -.
DR   PDBsum; 6QH7; -.
DR   PDBsum; 6URI; -.
DR   PDBsum; 6YAE; -.
DR   PDBsum; 6YAF; -.
DR   PDBsum; 6YAH; -.
DR   PDBsum; 7OG1; -.
DR   PDBsum; 7OHO; -.
DR   PDBsum; 7Z5C; -.
DR   AlphaFoldDB; P18484; -.
DR   BMRB; P18484; -.
DR   EMDB; EMD-10748; -.
DR   EMDB; EMD-10751; -.
DR   EMDB; EMD-14517; -.
DR   EMDB; EMD-14525; -.
DR   EMDB; EMD-14526; -.
DR   EMDB; EMD-20217; -.
DR   SMR; P18484; -.
DR   CORUM; P18484; -.
DR   DIP; DIP-29765N; -.
DR   IntAct; P18484; 14.
DR   MINT; P18484; -.
DR   STRING; 10116.ENSRNOP00000060992; -.
DR   CarbonylDB; P18484; -.
DR   GlyGen; P18484; 1 site, 1 O-linked glycan (1 site).
DR   PhosphoSitePlus; P18484; -.
DR   jPOST; P18484; -.
DR   PaxDb; 10116-ENSRNOP00000060992; -.
DR   PeptideAtlas; P18484; -.
DR   UCSC; RGD:71015; rat.
DR   AGR; RGD:71015; -.
DR   RGD; 71015; Ap2a2.
DR   eggNOG; KOG1077; Eukaryota.
DR   InParanoid; P18484; -.
DR   Reactome; R-RNO-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-RNO-2132295; MHC class II antigen presentation.
DR   Reactome; R-RNO-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-RNO-437239; Recycling pathway of L1.
DR   Reactome; R-RNO-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-RNO-5140745; WNT5A-dependent internalization of FZD2, FZD5 and ROR2.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-RNO-8964038; LDL clearance.
DR   EvolutionaryTrace; P18484; -.
DR   PRO; PR:P18484; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030122; C:AP-2 adaptor complex; IMP:CAFA.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0030117; C:membrane coat; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045202; C:synapse; IDA:SynGO.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0035615; F:clathrin adaptor activity; IBA:GO_Central.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0019900; F:kinase binding; ISO:RGD.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IMP:CAFA.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0120283; F:protein serine/threonine kinase binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; ISS:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISO:RGD.
DR   Gene3D; 2.60.40.1230; -; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   Gene3D; 3.30.310.10; TATA-Binding Protein; 1.
DR   IDEAL; IID50129; -.
DR   InterPro; IPR050840; Adaptor_Complx_Large_Subunit.
DR   InterPro; IPR017104; AP2_complex_asu.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002553; Clathrin/coatomer_adapt-like_N.
DR   InterPro; IPR003164; Clathrin_a-adaptin_app_sub_C.
DR   InterPro; IPR008152; Clathrin_a/b/g-adaptin_app_Ig.
DR   InterPro; IPR013041; Clathrin_app_Ig-like_sf.
DR   InterPro; IPR009028; Coatomer/calthrin_app_sub_C.
DR   InterPro; IPR012295; TBP_dom_sf.
DR   PANTHER; PTHR22780; ADAPTIN, ALPHA/GAMMA/EPSILON; 1.
DR   PANTHER; PTHR22780:SF30; AP-2 COMPLEX SUBUNIT ALPHA-2; 1.
DR   Pfam; PF01602; Adaptin_N; 1.
DR   Pfam; PF02296; Alpha_adaptin_C; 1.
DR   Pfam; PF02883; Alpha_adaptinC2; 1.
DR   PIRSF; PIRSF037091; AP2_complex_alpha; 1.
DR   SMART; SM00809; Alpha_adaptinC2; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF49348; Clathrin adaptor appendage domain; 1.
DR   SUPFAM; SSF55711; Subdomain of clathrin and coatomer appendage domain; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Coated pit; Direct protein sequencing;
KW   Endocytosis; Lipid-binding; Membrane; Protein transport;
KW   Reference proteome; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:1325787,
FT                   ECO:0000269|PubMed:2495531"
FT   CHAIN           2..938
FT                   /note="AP-2 complex subunit alpha-2"
FT                   /id="PRO_0000193734"
FT   REGION          615..681
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        615..638
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         11..12
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT                   /evidence="ECO:0000305|PubMed:12086608,
FT                   ECO:0000305|PubMed:25061211, ECO:0007744|PDB:2VGL,
FT                   ECO:0007744|PDB:4UQI"
FT   BINDING         43
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT                   /evidence="ECO:0000305|PubMed:12086608,
FT                   ECO:0000305|PubMed:25061211, ECO:0007744|PDB:2VGL,
FT                   ECO:0007744|PDB:4UQI"
FT   BINDING         53
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT                   /evidence="ECO:0000305|PubMed:12086608,
FT                   ECO:0000305|PubMed:25061211, ECO:0007744|PDB:2VGL,
FT                   ECO:0007744|PDB:4UQI"
FT   BINDING         57..61
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT                   /evidence="ECO:0000305|PubMed:12086608,
FT                   ECO:0000305|PubMed:25061211, ECO:0007744|PDB:2VGL,
FT                   ECO:0007744|PDB:4UQI"
FT   HELIX           11..22
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           26..43
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          46..48
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           52..67
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           76..84
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           88..100
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           106..121
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           125..138
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           141..147
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           150..156
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:2VGL"
FT   HELIX           162..178
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           180..182
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           189..195
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           201..217
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           219..222
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           225..237
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   TURN            240..242
FT                   /evidence="ECO:0007829|PDB:6URI"
FT   STRAND          243..245
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          248..251
FT                   /evidence="ECO:0007829|PDB:6URI"
FT   STRAND          252..254
FT                   /evidence="ECO:0007829|PDB:2VGL"
FT   HELIX           255..264
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           265..267
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          268..270
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           273..289
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           299..319
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           323..336
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           342..355
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          356..358
FT                   /evidence="ECO:0007829|PDB:6QH7"
FT   HELIX           359..366
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           369..376
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           382..394
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   TURN            398..400
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           401..413
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           417..419
FT                   /evidence="ECO:0007829|PDB:6URI"
FT   HELIX           420..434
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           438..452
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           453..455
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           458..467
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   TURN            468..470
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           472..474
FT                   /evidence="ECO:0007829|PDB:4UQI"
FT   HELIX           475..486
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          488..490
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           493..506
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           508..511
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           514..516
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           518..529
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           534..550
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           552..554
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           555..563
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           565..568
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           573..585
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           592..597
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          598..600
FT                   /evidence="ECO:0007829|PDB:2VGL"
FT   HELIX           610..616
FT                   /evidence="ECO:0007829|PDB:6URI"
SQ   SEQUENCE   938 AA;  104045 MW;  406428A9BFFB1E53 CRC64;
     MPAVSKGEGM RGLAVFISDI RNCKSKEAEI KRINKELANI RSKFKGDKAL DGYSKKKYVC
     KLLFIFLLGH DIDFGHMEAV NLLSSNRYTE KQIGYLFISV LVNSNSELIR LINNAIKNDL
     ASRNPTFMGL ALHCIANVGS REMAEAFAGE IPKILVAGDT MDSVKQSAAL CLLRLYRTSP
     DLVPMGDWTS RVVHLLNDQH LGVVTAATSL ITTLAQKNPE EFKTSVSLAV SRLSRIVTSA
     STDLQDYTYY FVPAPWLSVK LLRLLQCYPP PDPAVRGRLT ECLETILNKA QEPPKSKKVQ
     HSNAKNAVLF EAISLIIHHD SEPNLLVRAC NQLGQFLQHR ETNLRYLALE SMCTLASSEF
     SHEAVKTHIE TVINALKTER DVSVRQRAVD LLYAMCDRSN AQQIVAEMLS YLETADYSIR
     EEIVLKVAIL AEKYAVDYTW YVDTILNLIR IAGDYVSEEV WYRVIQIVIN RDDVQGYAAK
     TVFEALQAPA CHENLVKVGG YILGEFGNLI AGDPRSSPLI QFNLLHSKFH LCSVPTRALL
     LSTYIKFVNL FPEVKATIQD VLRSDSQLKN ADVELQQRAV EYLRLSTVAS TDILATVLEE
     MPPFPERESS ILAKLKKKKG PSTVTDLEET KRERSIDVNG GPEPVPASTS AASTPSPSAD
     LLGLGAVPPA PTGPPPSSGG GLLVDVFSDS ASAVAPLAPG SEDNFARFVC KNNGVLFENQ
     LLQIGLKSEF RQNLGRMFIF YGNKTSTQFL NFTPTLICAD DLQTNLNLQT KPVDPTVDGG
     AQVQQVINIE CISDFTEAPV LNIQFRYGGT FQNVSVKLPI TLNKFFQPTE MASQDFFQRW
     KQLSNPQQEV QNIFKAKHPM DTEITKAKII GFGSALLEEV DPNPANFVGA GIIHTKTTQI
     GCLLRLEPNL QAQMYRLTLR TSKDTVSQRL CELLSEQF
//
